Amyloid beta aggregates in cerebro spinal fluid as biomarkers for Alzheimer's disease

Details for Australian Patent Application No. 2010324588 (hide)

Owner Novartis AG

Inventors Peretz, David; Allauzen, Sophie; Wang, Xuemei; Gao, Man (carol); Yam, Alice; Fedynyshyn, Joseph

Agent FB Rice

Pub. Number AU-A-2010324588

PCT Pub. Number WO2011/066583

Priority 61/265,340 30.11.09 US

Filing date 30 November 2010

Wipo publication date 3 June 2011

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/066583 Priority application(s): WO2011/066583

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324594-Methods and systems for isolating, storing, and analyzing vesicles

2010324577-Assays for mutagenesis detection